Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem

Published:2020-02-01 Issue:2 Volume:30 Page:229-236
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Nervo Alice¹,Ragni Alberto¹,Gallo Marco¹,Ferraris Andrea²,Fonio Paolo²,Piovesan Alessandro¹,Arvat Emanuela¹

Affiliation:

1. Oncological Endocrinology Unit, Department of Medical Sciences, Città della Salute e della Scienza Hospital, University of Turin, Turin, Italy.

2. Division of Diagnostic Imaging, Department of Surgical Sciences, Città della Salute e della Scienza Hospital, University of Turin, Turin, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2019.0355

Reference35 articles.

1. 65 YEARS OF THE DOUBLE HELIX: Classification of endocrine tumors in the age of integrated genomics

2. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

3. Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy

4. Targeted Therapy in Thyroid Cancer: State of the Art

5. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features;Journal of Endocrinological Investigation;2023-04-21

2. Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting;Thyroid;2023-01-01

3. Liver Oncologic Surgical Emergencies;Oncologic Surgical Emergencies;2023

4. Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective;Cancer Management and Research;2022-10

5. Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma;Frontiers in Oncology;2022-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3